within Pharmacolibrary.Drugs.N_NervousSystem.N03A_Antiepileptics.N03AX14_Levetiracetam;
model Levetiracetam 
   extends Pharmacolibrary.Drugs.ATC.N.N03AX14;

  annotation(Documentation(
    info ="<html><body><p>Levetiracetam is an anticonvulsant medication used primarily for the treatment of epilepsy. It is indicated as adjunctive therapy for partial onset seizures, myoclonic seizures, and tonic-clonic seizures in adults and children. Levetiracetam is widely approved and used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after oral administration.</p><h4>References</h4><ol><li><p>Radtke, RA (2001). Pharmacokinetics of levetiracetam. <i>Epilepsia</i> 42 Suppl 4 24–27. DOI:<a href=&quot;https://doi.org/10.1046/j.1528-1157.2001.0420s4024.x&quot;>10.1046/j.1528-1157.2001.0420s4024.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11564121/&quot;>https://pubmed.ncbi.nlm.nih.gov/11564121</a></p></li><li><p>Barnard, L, et al., &amp; Boothe, DM (2018). Pharmacokinetics of Single Oral Dose Extended-Release Levetiracetam in Healthy Cats. <i>Journal of veterinary internal medicine</i> 32(1) 348–351. DOI:<a href=&quot;https://doi.org/10.1111/jvim.14863&quot;>10.1111/jvim.14863</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29114943/&quot;>https://pubmed.ncbi.nlm.nih.gov/29114943</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Levetiracetam;
